Letters to the Editor
Letter to the Editor: Metabolic Changes in Patients with Schizophrenia Switched from Olanzapine to Asenaprine or Clozapine
By Masaru Nakamura, MD, PhD, and Takahiko Nagamine, MD, PhD Funding/financial disclosures: The author has no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Innov Clin Neurosci. 2018;15(7–8):11–14 Dear Editor: The second-generation antipsychotics (SGAs) that focus on dopamine-2 plus serotonin-2A receptor antagonism are first-line treatments in […]
Letter to the Editor: Regarding Zika Microcephaly
By Beuy Joob, PhD, and Viroj Wiwanitkit, MD Funding/financial disclosures: The authors have no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Dear Editor: We read the article on zika microcephaly, which was published in the September-October 2017 issue of ICNS with a great interest.[1] Kolikonda […]
Letter to the Editor: Can YouTube® Disseminate Dementia Knowledge to Sinagpore Chinese?
By Benjamin K.P. Woo, MD Funding/financial disclosures: The authors have no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Dear Editor: A community-based epidemiological survey has suggested that the prevalence of cognitive impairment and dementia is approximately 15.2 percent in Singapore Chinese.[1] While early […]
